Abiopharma

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

Incyte Japan maakt de goedkeuring bekend van Zynyz® (retifanlimab) voor eerstelijnsbehandeling van anale kanker in een gevorderd stadium

Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema

NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS

Medi Lifestyle - Announcement

INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Gross Law Firm Reminds Integer Holdings Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 9, 2026 - ITGR

January 5, 2026 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INSP